Health Pharma

Avarice Is Truly So Addictive

Gilead’s Lenacapavir Price Cut: A Monopoly Tactic? Gilead Sciences’ recent announcement of reduced prices for lenacapavir, its innovative HIV prevention drug, in select nations has […]